Exome Asset Management’s CVS Health CVS Stock Holding History

Exome Asset Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-43,600	Closed	-$3.29M	–	70
2025 Q3	$3.29M	Buy	+43,600	New	+$2.99M	1.99%	17

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Exome Asset Management's CVS Position: Q4 2025 in Review

Exome Asset Management sold out of CVS Health (CVS) in Q4 2025, closing a stake of 43,600 shares — an estimated $3.29M sold.

Exome Asset Management first reported a position in CVS in Q3 2025 and held it in 1 quarter. The position peaked at $3.29M in Q3 2025. 1,945 funds tracked by Wall St. Rank hold CVS as of Q4 2025.

Exome Asset Management reported no remaining CVS Health position as of Q4 2025 after selling out during the quarter.
Exome Asset Management sold 43,600 CVS Health shares in Q4 2025, an estimated $3.29M.
Exome Asset Management first reported a position in CVS Health in Q3 2025 and held it in 1 quarter.
Exome Asset Management's CVS Health position peaked at $3.29M in Q3 2025.
1,945 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.

Based on Exome Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.